Since CXCR2 may also stimulate tumor endothelial cells [34], we measured the expression of intratumoral CD31 and found no changes upon the therapy (Figure S8), indicating the absence of effect on tumor vascularization. The gene discussed is CXCR2; the disease is neoplasm.